|
1
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264.e1–1273.e1. 2012. View Article : Google Scholar
|
|
2
|
Su Y, Yang Y, Ma Y, Zhang Y, Rao W, Yang G
and Kou C: The Efficacy and Safety of Dendritic Cells Co-Cultured
with Cytokine-Induced Killer Cell Therapy in Combination with
TACE-Predominant Minimally-Invasive Treatment for Hepatocellular
Carcinoma: A Meta-Analysis. Clin Lab. 62:599–608. 2016.PubMed/NCBI
|
|
3
|
Zhang L, Zhu W, Li J, Yang X, Ren Y, Niu J
and Pang Y: Clinical outcome of immunotherapy with dendritic cell
vaccine and cytokine-induced killer cell therapy in hepatobiliary
and pancreatic cancer. Mol Clin Oncol. 4:129–133. 2016.PubMed/NCBI
|
|
4
|
Schmidt-Wolf IG, Finke S, Trojaneck B,
Denkena A, Lefterova P, Schwella N, Heuft HG, Prange G, Korte M,
Takeya M, et al: Phase I clinical study applying autologous
immunological effector cells transfected with the interleukin-2
gene in patients with metastatic renal cancer, colorectal cancer
and lymphoma. Br J Cancer. 81:1009–1016. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rettinger E, Meyer V, Kreyenberg H, Volk
A, Kuçi S, Willasch A, Koscielniak E, Fulda S, Wels WS, Boenig H,
et al: Cytotoxic capacity of IL-15-stimulated cytokine-induced
killer cells against human acute myeloid leukemia and
rhabdomyosarcoma in humanized preclinical mouse models. Front
Oncol. 2:322012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang X, Chen YT, Song HZ, Huang GC and
Chen LB: Cisplatin pretreatment enhances antitumor activity of
cytokine-induced killer cells. World J Gastroenterol. 17:3002–3011.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang D, Zhang B, Gao H, Ding G, Wu Q,
Zhang J, Liao L and Chen H: Clinical research of genetically
modified dendritic cells in combination with cytokine-induced
killer cell treatment in advanced renal cancer. BMC Cancer.
14:2512014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie F, Zhang X, Li H, Zheng T, Xu F, Shen
R, Yan L, Yang J and He J: Adoptive immunotherapy in postoperative
hepatocellular carcinoma: A systemic review. PLoS One.
7:e428792012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cantor JR and Sabatini DM: Cancer cell
metabolism: One hallmark, many faces. Cancer Discov. 2:881–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Andersen AP, Moreira JM and Pedersen SF:
Interactions of ion transporters and channels with cancer cell
metabolism and the tumour microenvironment. Philos Trans R Soc Lond
B Biol Sci. 369:201300982014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gallagher FA, Kettunen MI, Day SE, Hu DE,
Ardenkjaer-Larsen JH, Zandt RI, Jensen PR, Karlsson M, Golman K,
Lerche MH and Brindle KM: Magnetic resonance imaging of pH in vivo
using hyperpolarized 13C-labelled bicarbonate. Nature. 453:940–943.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rofstad EK, Mathiesen B, Kindem K and
Galappathi K: Acidic extracellular pH promotes experimental
metastasis of human melanoma cells in athymic nude mice. Cancer
Res. 66:6699–6707. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barar J and Omidi Y: Dysregulated pH in
tumor microenvironment checkmates cancer therapy. Bioimpacts.
3:149–162. 2013.PubMed/NCBI
|
|
14
|
von Schwarzenberg K, Lajtos T, Simon L,
Müller R, Vereb G and Vollmar AM: V-ATPase inhibition overcomes
trastuzumab resistance in breast cancer. Mol Oncol. 8:9–19. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ferrari M, Fornasiero MC and Isetta AM:
MTT colorimetric assay for testing macrophage cytotoxic activity in
vitro. J Immunol Methods. 131:165–172. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pyo KH, Jung BK, Xin CF, Lee YW, Chai JY
and Shin EH: Prominent IL-12 production and tumor reduction in
athymic nude mice after Toxoplasma gondii lysate antigen treatment.
Korean J Parasitol. 52:605–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen JH, Xiang JY, Ding GP and Cao LP:
Cholangiocarcinoma-derived exosomes inhibit the antitumor activity
of cytokine-induced killer cells by down-regulating the secretion
of tumor necrosis factor-α and perforin. J Zhejiang Univ Sci B.
17:537–544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lardner A: The effects of extracellular pH
on immune function. J Leukoc Biol. 69:522–530. 2001.PubMed/NCBI
|
|
19
|
Rabinovich M, DeStefano MJ and
Dziezanowski MA: Neutrophil migration under agarose: Stimulation by
lowered medium pH and osmolality. J Reticuloendothel Soc.
27:189–200. 1980.PubMed/NCBI
|
|
20
|
Leblebicioglu B, Lim JS, Cario AC, Beck FM
and Walters JD: pH changes observed in the inflamed gingival
crevice modulate human polymorphonuclear leukocyte activation in
vitro. J Periodontol. 67:472–477. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Loeffler DA, Juneau PL and Masserant S:
Influence of tumour physico-chemical conditions on
interleukin-2-stimulated lymphocyte proliferation. Br J Cancer.
66:619–622. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kellum JA, Song M and Li J: Science
review: Extracellular acidosis and the immune response: Clinical
and physiologic implications. Crit Care. 8:331–336. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kraus M and Wolf B: Implications of acidic
tumor microenvironment for neoplastic growth and cancer treatment:
A computer analysis. Tumour Biol. 17:133–154. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishimura R, Baker J, Beilhack A, Zeiser
R, Olson JA, Sega EI, Karimi M and Negrin RS: In vivo trafficking
and survival of cytokine-induced killer cells resulting in minimal
GVHD with retention of antitumor activity. Blood. 112:2563–2574.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pievani A, Borleri G, Pende D, Moretta L,
Rambaldi A, Golay J and Introna M: Dual-functional capability of
CD3+CD56+CIK cells, a T-cell subset that acquires NK function and
retains TCR-mediated specific cytotoxicity. Blood. 118:3301–3310.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miao L, Run-Ming J and Yi J: T-Bet
mediated anti-neoplastic effects of dendritic cell-cytokine induced
killer cells in vitro. Iran J Pediatr. 22:43–51. 2012.PubMed/NCBI
|
|
27
|
Martin NK, Gaffney EA, Gatenby RA, Gillies
RJ, Robey IF and Maini PK: A mathematical model of tumour and blood
pHe regulation: The HCO3-/CO2 buffering system. Math Biosci.
230:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Robey IF, Baggett BK, Kirkpatrick ND, Roe
DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby
RA and Gillies RJ: Bicarbonate increases tumor pH and inhibits
spontaneous metastases. Cancer Res. 69:2260–2268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wojtkowiak JW, Verduzco D, Schramm KJ and
Gillies RJ: Drug resistance and cellular adaptation to tumor acidic
pH microenvironment. Mol Pharm. 8:2032–2038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Estrella V, Chen T, Lloyd M, Wojtkowiak J,
Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg
JM, Sloane BF, et al: Acidity generated by the tumor
microenvironment drives local invasion. Cancer Res. 73:1524–1535.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Silva AS, Yunes JA, Gillies RJ and Gatenby
RA: The potential role of systemic buffers in reducing intratumoral
extracellular pH and acid-mediated invasion. Cancer Res.
69:2677–2684. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Robey IF and Nesbit LA: Investigating
mechanisms of alkalinization for reducing primary breast tumor
invasion. Biomed Res Int. 2013:4851962013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chu H, Du F, Jiang L, Wang Z, Gong Z, Lian
P, Li P and Chen J: The Efficacy of CIK-Based Immunotherapies for
Advanced Solid Tumors. Technol Cancer Res Treat. Jul 19–2016.(Epub
ahead of print).
|
